{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:33:26Z","timestamp":1792427606785,"version":"4.5.0"},"reference-count":170,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4,1]]},"abstract":"<jats:p>Lysosomal storage disorders are rare inborn errors of metabolism, with a combined incidence of 1 in 1500 to 7000 live births. These relatively rare disorders are seldom considered when evaluating a sick newborn. A significant number of the &amp;gt;50 different lysosomal storage disorders, however, do manifest in the neonatal period and should be part of the differential diagnosis of several perinatal phenotypes. We review the earliest clinical features, diagnostic tests, and treatment options for lysosomal storage disorders that can present in the newborn. Although many of the lysosomal storage disorders are characterized by a range in phenotypes, the focus of this review is on the specific symptoms and clinical findings that present in the perinatal period, including neurologic, respiratory, endocrine, and cardiovascular manifestations, dysmorphic features, hepatosplenomegaly, skin or ocular involvement, and hydrops fetalis\/congenital ascites. A greater awareness of these features may help to reduce misdiagnosis and promote the early detection of lysosomal storage disorders. Implementing therapy at the earliest stage possible is crucial for several of the lysosomal storage disorders; hence, an early appreciation of these disorders by physicians who treat newborns is essential.<\/jats:p>","DOI":"10.1542\/peds.2008-0635","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T23:05:24Z","timestamp":1238454324000},"page":"1191-1207","source":"Crossref","is-referenced-by-count":154,"title":["Lysosomal Storage Disorders in the Newborn"],"prefix":"10.1542","volume":"123","author":[{"given":"Orna","family":"Staretz-Chacham","sequence":"first","affiliation":[{"name":"Office of the Clinical Director"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tess C.","family":"Lang","sequence":"additional","affiliation":[{"name":"Section on Molecular Neurogenetics, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"LaMarca","sequence":"additional","affiliation":[{"name":"Section on Molecular Neurogenetics, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Krasnewich","sequence":"additional","affiliation":[{"name":"Office of the Clinical Director"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Sidransky","sequence":"additional","affiliation":[{"name":"Section on Molecular Neurogenetics, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2009,4,1]]},"reference":[{"key":"2021120902352169600_R1","doi-asserted-by":"crossref","unstructured":"Stone DL, Sidransky E. Hydrops fetalis: lysosomal storage disorders in extremis. Adv Pediatr.\u20081999;46:409\u2013440","DOI":"10.1016\/S0065-3101(24)00037-9"},{"key":"2021120902352169600_R2","doi-asserted-by":"crossref","unstructured":"Fletcher JM. Screening for lysosomal storage disorders: a clinical perspective. J Inherit Metab Dis.\u20082006;29(2\u20133):405\u2013408","DOI":"10.1007\/s10545-006-0246-7"},{"key":"2021120902352169600_R3","unstructured":"Beaudet AL, Scriver CR, Sly WS, Valle D. Genetics, biochemistry and molecular basis of variant human phenotypes. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York, NY: McGraw-Hill; 1995:53\u2013118"},{"key":"2021120902352169600_R4","doi-asserted-by":"crossref","unstructured":"Wraith JE. Lysosomal disorders. Semin Neonatol.\u20082002;7(1):75\u201383","DOI":"10.1053\/siny.2001.0088"},{"key":"2021120902352169600_R5","doi-asserted-by":"crossref","unstructured":"Futerman AH, van Meer G. The cell biology of lysosomal storage disorders. Nat Rev Mol Cell Biol.\u20082004;5(7):554\u2013565","DOI":"10.1038\/nrm1423"},{"key":"2021120902352169600_R6","doi-asserted-by":"crossref","unstructured":"Vellodi A. Lysosomal storage disorders. Br J Haematol.\u20082005;128(4):413\u2013431","DOI":"10.1111\/j.1365-2141.2004.05293.x"},{"key":"2021120902352169600_R7","unstructured":"Beutler E, Grabowski GA. Gaucher disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York, NY: McGraw-Hill; 1995:2641\u20132670"},{"key":"2021120902352169600_R8","doi-asserted-by":"crossref","unstructured":"Sakuraba H, Suzuki Y, Akagi M, Sakai M, Amano N. Beta-galactosidase-neuraminidase deficiency (galactosialidosis): clinical, pathological, and enzymatic studies in a postmortem case. Ann Neurol.\u20081983;13(5):497\u2013503","DOI":"10.1002\/ana.410130505"},{"key":"2021120902352169600_R9","doi-asserted-by":"crossref","unstructured":"Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr.\u20082006;148(5):671\u2013676","DOI":"10.1016\/j.jpeds.2005.11.033"},{"key":"2021120902352169600_R10","doi-asserted-by":"crossref","unstructured":"Howell RR, Byrne B, Darras BT, Kishnani P, Nicolino M, van der Ploeg A. Diagnostic challenges for Pompe disease: an under-recognized cause of floppy baby syndrome. Genet Med.\u20082006;8(5):289\u2013296","DOI":"10.1097\/01.gim.0000204462.42910.b8"},{"key":"2021120902352169600_R11","doi-asserted-by":"crossref","unstructured":"Verity MA. Infantile Pompe's disease, lipid storage, and partial carnitine deficiency. Muscle Nerve.\u20081991;14(5):435\u2013440","DOI":"10.1002\/mus.880140509"},{"key":"2021120902352169600_R12","doi-asserted-by":"crossref","unstructured":"Sarfati R, Hubert A, Dugue-Marechaud M, Biran-Mucignat V, Pierre F, Bonneau D. Prenatal diagnosis of Gaucher's disease type 2: ultrasonographic, biochemical and histological aspects. Prenat Diagn.\u20082000;20(4):340\u2013343","DOI":"10.1002\/(SICI)1097-0223(200004)20:4<340::AID-PD795>3.0.CO;2-N"},{"key":"2021120902352169600_R13","doi-asserted-by":"crossref","unstructured":"Mignot C, Gelot A, Bessieres B, et al. Perinatal-lethal Gaucher disease. Am J Med Genet A.\u20082003;120A(3):338\u2013344","DOI":"10.1002\/ajmg.a.20117"},{"key":"2021120902352169600_R14","doi-asserted-by":"crossref","unstructured":"Eblan MJ, Goker-Alpan O, Sidransky E. Perinatal lethal Gaucher disease: a distinct phenotype along the neuronopathic continuum. Fetal Pediatr Pathol.\u20082005;24(4\u20135):205\u2013222","DOI":"10.1080\/15227950500405296"},{"key":"2021120902352169600_R15","doi-asserted-by":"crossref","unstructured":"Ida H, Rennert OM, Watabe K, Eto Y, Maekawa K. Pathological and biochemical studies of fetal Krabbe disease. Brain Dev.\u20081994;16(6):480\u2013484","DOI":"10.1016\/0387-7604(94)90013-2"},{"key":"2021120902352169600_R16","doi-asserted-by":"crossref","unstructured":"Sahai I, Baris H, Kimonis V, Levy HL. Krabbe disease: severe neonatal presentation with a family history of multiple sclerosis. J Child Neurol.\u20082005;20(10):826\u2013828","DOI":"10.1177\/08830738050200100901"},{"key":"2021120902352169600_R17","doi-asserted-by":"crossref","unstructured":"Korn-Lubetzki I, Dor-Wollman T, Soffer D, Raas-Rothschild A, Hurvitz H, Nevo Y. Early peripheral nervous system manifestations of infantile Krabbe disease. Pediatr Neurol.\u20082003;28(2):115\u2013118","DOI":"10.1016\/S0887-8994(02)00489-7"},{"key":"2021120902352169600_R18","doi-asserted-by":"crossref","unstructured":"Clarke JT, Ozere RL, Krause VW. Early infantile variant of Krabbe globoid cell leucodystrophy with lung involvement. Arch Dis Child.\u20081981;56(8):640\u2013642","DOI":"10.1136\/adc.56.8.640-a"},{"key":"2021120902352169600_R19","unstructured":"Gu\u0308ngo\u0308r N, Cos\u0327kun T, Akc\u0327o\u0308ren Z, Cag\u0306lar M. I-cell disease: a case report and review of the literature. Turk J Pediatr.\u20081994;36(2):145\u2013152"},{"key":"2021120902352169600_R20","doi-asserted-by":"crossref","unstructured":"Denis R, Wayenberg JL, Vermeulen M, et al. Hyperphosphatasemia in early diagnosed infantile GM1 gangliosidosis presenting as transient hydrops fetalis. Acta Clin Belg.\u20081996;51(5):320\u2013327","DOI":"10.1080\/22953337.1996.11718526"},{"key":"2021120902352169600_R21","doi-asserted-by":"crossref","unstructured":"Morrone A, Bardelli T, Donati MA, et al. Beta-galactosidase gene mutations affecting the lysosomal enzyme and the elastin-binding protein in GM1-gangliosidosis patients with cardiac involvement. Hum Mutat.\u20082000;15(4):354\u2013366","DOI":"10.1002\/(SICI)1098-1004(200004)15:4<354::AID-HUMU8>3.0.CO;2-L"},{"key":"2021120902352169600_R22","doi-asserted-by":"crossref","unstructured":"Simpson MA, Cross H, Proukakis C, et al. Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet.\u20082004;36(11):1225\u20131229","DOI":"10.1038\/ng1460"},{"key":"2021120902352169600_R23","doi-asserted-by":"crossref","unstructured":"Elleder M, Jerabkova M, Befekadu A, et al. Prosaposin deficiency: a rarely diagnosed, rapidly progressing, neonatal neurovisceral lipid storage disease. Report of a further patient. Neuropediatrics.\u20082005;36(3):171\u2013180","DOI":"10.1055\/s-2005-865608"},{"key":"2021120902352169600_R24","doi-asserted-by":"crossref","unstructured":"Burch M, Fensom AH, Jackson M, Pitts-Tucker T, Congdon PJ. Multiple sulphatase deficiency presenting at birth. Clin Genet.\u20081986;30(5):409\u2013415","DOI":"10.1111\/j.1399-0004.1986.tb01899.x"},{"key":"2021120902352169600_R25","doi-asserted-by":"crossref","unstructured":"Santos RP, Hoo JJ. Difficulty in recognizing multiple sulfatase deficiency in an infant. Pediatrics.\u20082006;117(3):955\u2013958","DOI":"10.1542\/peds.2005-1032"},{"key":"2021120902352169600_R26","doi-asserted-by":"crossref","unstructured":"Inui K, Yanagihara K, Otani K, et al. A new variant neuropathic type of Gaucher's disease characterized by hydrocephalus, corneal opacities, deformed toes, and fibrous thickening of spleen and liver capsules. J Pediatr.\u20082001;138(1):137\u2013139","DOI":"10.1067\/mpd.2001.109789"},{"key":"2021120902352169600_R27","doi-asserted-by":"crossref","unstructured":"Tylki-Szymanska A, Lugowska A, Czartoryska B. Neuraminidase deficiency presenting as a nephrosialidosis: the first case detected in Poland. Acta Paediatr Jpn.\u20081996;38(5):529\u2013532","DOI":"10.1111\/j.1442-200X.1996.tb03539.x"},{"key":"2021120902352169600_R28","doi-asserted-by":"crossref","unstructured":"Hoyme HE, Jones KL, Higginbottom MC, O'Brien JS. Presentation of mucopolysaccharidosis VII (beta-glucuronidase deficiency) in infancy. J Med Genet.\u20081981;18(3):237\u2013239","DOI":"10.1136\/jmg.18.3.237"},{"key":"2021120902352169600_R29","doi-asserted-by":"crossref","unstructured":"Arda IS, Genc\u0327og\u0306lu A, Cos\u0327kun M, Ozbek N, Demirhan B, Hic\u0327so\u0308nmez A. A very unusual presentation of Niemann-Pick disease type B in an infant: similar findings to congenital lobar emphysema. Eur J Pediatr Surg.\u20082005;15(4):283\u2013286","DOI":"10.1055\/s-2004-830362"},{"key":"2021120902352169600_R30","doi-asserted-by":"crossref","unstructured":"Morisot C, Millat G, Coeslier A, et al. Fatal neonatal respiratory distress in Niemann-Pick C2 and prenatal diagnosis with mutations in gene HE1\/NPC2 [in French]. Arch Pediatr.\u20082005;12(4):434\u2013437","DOI":"10.1016\/j.arcped.2005.01.015"},{"key":"2021120902352169600_R31","doi-asserted-by":"crossref","unstructured":"Kishnani PS, Steiner RD, Bali D, et al. Pompe disease diagnosis and management guideline. Genet Med.\u20082006;8(5):267\u2013288","DOI":"10.1097\/01.gim.0000218152.87434.f3"},{"key":"2021120902352169600_R32","unstructured":"Akcam M. Infantile Pompe's disease presenting with pulmonary infections during the newborn period. Saudi Med J.\u20082004;25(12):2022\u20132023"},{"key":"2021120902352169600_R33","doi-asserted-by":"crossref","unstructured":"Metzl JD, Elias ER, Berul CI. An interesting case of infant sudden death: severe hypertrophic cardiomyopathy in Pompe's disease. Pacing Clin Electrophysiol.\u20081999;22(5):821\u2013822","DOI":"10.1111\/j.1540-8159.1999.tb00551.x"},{"key":"2021120902352169600_R34","doi-asserted-by":"crossref","unstructured":"Devi AR, Gopikrishna M, Ratheesh R, Savithri G, Swarnalata G, Bashyam M. Farber lipogranulomatosis: clinical and molecular genetic analysis reveals a novel mutation in an Indian family. J Hum Genet.\u20082006;51(9):811\u2013814","DOI":"10.1007\/s10038-006-0019-z"},{"key":"2021120902352169600_R35","doi-asserted-by":"crossref","unstructured":"Unger S, Paul DA, Nino MC, et al. Mucolipidosis II presenting as severe neonatal hyperparathyroidism. Eur J Pediatr.\u20082005;164(4):236\u2013243","DOI":"10.1007\/s00431-004-1591-x"},{"key":"2021120902352169600_R36","doi-asserted-by":"crossref","unstructured":"Patriquin HB, Kaplan P, Kind HP, Giedion A. Neonatal mucolipidosis II (I-cell disease): clinical and radiologic features in three cases. AJR Am J Roentgenol.\u20081977;129(1):37\u201343","DOI":"10.2214\/ajr.129.1.37"},{"key":"2021120902352169600_R37","unstructured":"Cipolloni C, Boldrini A, Donti E, Maiorana A, Coppa GV. Neonatal mucolipidosis II (I-cell disease): clinical, radiological and biochemical studies in a case. Helv Paediatr Acta.\u20081980;35(1):85\u201395"},{"key":"2021120902352169600_R38","doi-asserted-by":"crossref","unstructured":"Babcock DS, Bove KE, Hug G, Dignan PS, Soukup S, Warren NS. Fetal mucolipidosis II (I-cell disease): radiologic and pathologic correlation. Pediatr Radiol.\u20081986;16(1):32\u201339","DOI":"10.1007\/BF02387502"},{"key":"2021120902352169600_R39","doi-asserted-by":"crossref","unstructured":"Pazzaglia UE, Beluffi G, Danesino C, Frediani PV, Pagani G, Zatti G. Neonatal mucolipidosis 2: the spontaneous evolution of early bone lesions and the effect of vitamin D treatment\u2014report of two cases. Pediatr Radiol.\u20081989;20(1\u20132):80\u201384","DOI":"10.1007\/BF02010640"},{"key":"2021120902352169600_R40","doi-asserted-by":"crossref","unstructured":"Beck M, Barone R, Hoffmann R, et al. Inter- and intrafamilial variability in mucolipidosis II (I-cell disease). Clin Genet.\u20081995;47(4):191\u2013199","DOI":"10.1111\/j.1399-0004.1995.tb03958.x"},{"key":"2021120902352169600_R41","unstructured":"Herman TE, McAlister WH. Neonatal mucolipidosis II (I-cell disease) with dysharmonic epiphyseal ossification and butterfly vertebral body. J Perinatol.\u20081996;16(5):400\u2013402"},{"key":"2021120902352169600_R42","doi-asserted-by":"crossref","unstructured":"Saul RA, Proud V, Taylor HA, Leroy JG, Spranger J. Prenatal mucolipidosis type II (I-cell disease) can present as Pacman dysplasia. Am J Med Genet A.\u20082005;135(3):328\u2013332","DOI":"10.1002\/ajmg.a.30716"},{"key":"2021120902352169600_R43","doi-asserted-by":"crossref","unstructured":"Sathasivam A, Garibaldi L, Murphy R, Ibrahim J. Transient neonatal hyperparathyroidism: a presenting feature of mucolipidosis type II. J Pediatr Endocrinol Metab.\u20082006;19(6):859\u2013862","DOI":"10.1515\/JPEM.2006.19.6.859"},{"key":"2021120902352169600_R44","doi-asserted-by":"crossref","unstructured":"Oohira T, Nagata N, Akaboshi I, Matsuda I, Naito S. The infantile form of sialidosis type II associated with congenital adrenal hyperplasia: possible linkage between HLA and the neuraminidase deficiency gene. Hum Genet.\u20081985;70(4):341\u2013343","DOI":"10.1007\/BF00295374"},{"key":"2021120902352169600_R45","doi-asserted-by":"crossref","unstructured":"Kyllerman M, Mansson JE, Westphal O, Conradi N, Nellstrom H. Infantile galactosialidosis presenting with congenital adrenal hyperplasia and renal hypertension. Pediatr Neurol.\u20081993;9(4):318\u2013322","DOI":"10.1016\/0887-8994(93)90073-L"},{"key":"2021120902352169600_R46","doi-asserted-by":"crossref","unstructured":"Noori S, Acherman R, Siassi B, et al. A rare presentation of Pompe disease with massive hypertrophic cardiomyopathy at birth. J Perinat Med.\u20082002;30(6):517\u2013521","DOI":"10.1515\/JPM.2002.081"},{"key":"2021120902352169600_R47","doi-asserted-by":"crossref","unstructured":"Bulkley BH, Hutchins GM. Pompe's disease presenting as hypertrophic myocardiopathy with Wolff-Parkinson-White syndrome. Am Heart J.\u20081978;96(2):246\u2013252","DOI":"10.1016\/0002-8703(78)90093-5"},{"key":"2021120902352169600_R48","doi-asserted-by":"crossref","unstructured":"Guertl B, Noehammer C, Hoefler G. Metabolic cardiomyopathies. Int J Exp Pathol.\u20082000;81(6):349\u2013372","DOI":"10.1046\/j.1365-2613.2000.00186.x"},{"key":"2021120902352169600_R49","doi-asserted-by":"crossref","unstructured":"Chaba\u0301s A, Duque J, Gort L. A new infantile case of alpha-N-acetylgalactosaminidase deficiency: cardiomyopathy as a presenting symptom. J Inherit Metab Dis.\u20082007;30(1):108","DOI":"10.1007\/s10545-006-0470-1"},{"key":"2021120902352169600_R50","doi-asserted-by":"crossref","unstructured":"Lee JE, Falk RE, Ng WG, Donnell GN. Beta-glucuronidase deficiency: a heterogeneous mucopolysaccharidosis. Am J Dis Child.\u20081985;139(1):57\u201359","DOI":"10.1001\/archpedi.1985.02140030059029"},{"key":"2021120902352169600_R51","doi-asserted-by":"crossref","unstructured":"den Hollander NS, Kleijer WJ, Schoonderwaldt EM, Los FJ, Wladimiroff JW, Niermeijer MF. In-utero diagnosis of mucopolysaccharidosis type VII in a fetus with an enlarged nuchal translucency. Ultrasound Obstet Gynecol.\u20082000;16(1):87\u201390","DOI":"10.1046\/j.1469-0705.2000.00148.x"},{"key":"2021120902352169600_R52","doi-asserted-by":"crossref","unstructured":"Arai Y, Edwards V, Takashima S, Becker LE. Vascular pathology in galactosialidosis. Ultrastruct Pathol.\u20081999;23(6):369\u2013374","DOI":"10.1080\/019131299281338"},{"key":"2021120902352169600_R53","doi-asserted-by":"crossref","unstructured":"Patel MS, Callahan JW, Zhang S, et al. Early-infantile galactosialidosis: prenatal presentation and postnatal follow-up. Am J Med Genet.\u20081999;85(1):38\u201347","DOI":"10.1002\/(SICI)1096-8628(19990702)85:1<38::AID-AJMG8>3.0.CO;2-3"},{"key":"2021120902352169600_R54","unstructured":"Gravel RA, Lowden JA, Callahan JW, Wolfe LS, Ng Yin Kin NM. Infantile sialidosis: a phenocopy of type 1 GM1 gangliosidosis distinguished by genetic complementation and urinary oligosaccharides. Am J Hum Genet.\u20081979;31(6):669\u2013679"},{"key":"2021120902352169600_R55","doi-asserted-by":"crossref","unstructured":"Finn LS, Zhang M, Chen SH, Scott CR. Severe type II Gaucher disease with ichthyosis, arthrogryposis and neuronal apoptosis: molecular and pathological analyses. Am J Med Genet.\u20082000;91(3):222\u2013226","DOI":"10.1002\/(SICI)1096-8628(20000320)91:3<222::AID-AJMG13>3.0.CO;2-#"},{"key":"2021120902352169600_R56","doi-asserted-by":"crossref","unstructured":"Beaudet AL, DiFerrante NM, Ferry GD, Nichols BL Jr, Mullins CE. Variation in the phenotypic expression of beta-glucuronidase deficiency. J Pediatr.\u20081975;86(3):388\u2013394","DOI":"10.1016\/S0022-3476(75)80968-1"},{"key":"2021120902352169600_R57","doi-asserted-by":"crossref","unstructured":"Gillett PM, Schreiber RA, Jevon GP, et al. Mucopolysaccharidosis type VII (Sly syndrome) presenting as neonatal cholestasis with hepatosplenomegaly. J Pediatr Gastroenterol Nutr.\u20082001;33(2):216\u2013220","DOI":"10.1097\/00005176-200108000-00025"},{"key":"2021120902352169600_R58","doi-asserted-by":"crossref","unstructured":"Nordborg C, Kyllerman M, Conradi N, Mansson JE. Early-infantile galactosialidosis with multiple brain infarctions: morphological, neuropathological and neurochemical findings. Acta Neuropathol (Berl).\u20081997;93(1):24\u201333","DOI":"10.1007\/s004010050579"},{"key":"2021120902352169600_R59","doi-asserted-by":"crossref","unstructured":"Pueschel SM, O'Shea PA, Alroy J, et al. Infantile sialic acid storage disease associated with renal disease. Pediatr Neurol.\u20081988;4(4):207\u2013212","DOI":"10.1016\/0887-8994(88)90032-X"},{"key":"2021120902352169600_R60","doi-asserted-by":"crossref","unstructured":"Harzer K, Paton BC, Poulos A, et al. Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses. Eur J Pediatr.\u20081989;149(1):31\u201339","DOI":"10.1007\/BF02024331"},{"key":"2021120902352169600_R61","doi-asserted-by":"crossref","unstructured":"Hulkova\u0301 H, Cervenkova M, Ledvinova J, et al. A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation. Hum Mol Genet.\u20082001;10(9):927\u2013940","DOI":"10.1093\/hmg\/10.9.927"},{"key":"2021120902352169600_R62","doi-asserted-by":"crossref","unstructured":"Semeraro LA, Riely CA, Kolodny EH, Dickerson GR, Gryboski JD. Niemann-Pick variant lipidosis presenting as \u201cneonatal hepatitis.\u201d J Pediatr Gastroenterol Nutr. 1986;5(3):492\u2013500","DOI":"10.1097\/00005176-198605000-00030"},{"key":"2021120902352169600_R63","doi-asserted-by":"crossref","unstructured":"Kelly DA, Portmann B, Mowat AP, Sherlock S, Lake BD. Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. J Pediatr.\u20081993;123(2):242\u2013247","DOI":"10.1016\/S0022-3476(05)81695-6"},{"key":"2021120902352169600_R64","doi-asserted-by":"crossref","unstructured":"Maconochie IK, Chong S, Mieli-Vergani G, Lake BD, Mowat AP. Fetal ascites: an unusual presentation of Niemann-Pick disease type C. Arch Dis Child. 1989;64(10 spec No.):1391\u20131393","DOI":"10.1136\/adc.64.10_Spec_No.1391"},{"key":"2021120902352169600_R65","doi-asserted-by":"crossref","unstructured":"Uno Y, Taniguchi A, Tanaka E. Histochemical studies in Wolman's disease: report of an autopsy case accompanied with a large amount of milky ascites. Acta Pathol Jpn.\u20081973;23(4):779\u2013790","DOI":"10.1111\/j.1440-1827.1973.tb02775.x"},{"key":"2021120902352169600_R66","unstructured":"Hoeg JM, Demosky SJ Jr, Pescovitz OH, Brewer HB Jr. Cholesteryl ester storage disease and Wolman disease: phenotypic variants of lysosomal acid cholesteryl ester hydrolase deficiency. Am J Hum Genet.\u20081984;36(6):1190\u20131203"},{"key":"2021120902352169600_R67","unstructured":"Perlmutter-Cremer N, Libert J, Vamos E, Spehl M, Liebaers I. Unusual early manifestation of multiple sulfatase deficiency [in English, French]. Ann Radiol (Paris).\u20081981;24(1):43\u201348"},{"key":"2021120902352169600_R68","doi-asserted-by":"crossref","unstructured":"Burk RD, Valle D, Thomas GH, et al. Early manifestations of multiple sulfatase deficiency. J Pediatr.\u20081984;104(4):574\u2013578","DOI":"10.1016\/S0022-3476(84)80550-8"},{"key":"2021120902352169600_R69","doi-asserted-by":"crossref","unstructured":"Lalwani SG, Kher A, Shridhar N, Bharucha BA, Naik GG. Mucolipidoses-II: a report of three cases. Indian J Pediatr.\u20081995;62(5):611\u2013614","DOI":"10.1007\/BF02761891"},{"key":"2021120902352169600_R70","doi-asserted-by":"crossref","unstructured":"Hochman JA, Treem WR, Dougherty F, Bentley RC. Mucolipidosis II (I-cell disease) presenting as neonatal cholestasis. J Inherit Metab Dis.\u20082001;24(5):603\u2013604","DOI":"10.1023\/A:1012428113606"},{"key":"2021120902352169600_R71","doi-asserted-by":"crossref","unstructured":"Barbier C, Devisme L, Dobbelaere D, Noizet O, Nelken B, Gottrand F. Neonatal cholestasis and infantile Gaucher disease: a case report. Acta Paediatr.\u20082002;91(12):1399\u20131401","DOI":"10.1111\/j.1651-2227.2002.tb02841.x"},{"key":"2021120902352169600_R72","doi-asserted-by":"crossref","unstructured":"Roth P, Sklower Brooks S, Potaznik D, Cooma R, Sahdev S. Neonatal Gaucher disease presenting as persistent thrombocytopenia. J Perinatol.\u20082005;25(5):356\u2013358","DOI":"10.1038\/sj.jp.7211262"},{"key":"2021120902352169600_R73","unstructured":"Adachi M, Wallace BJ, Schneck L, Volk BW. Fine structure of central nervous system in early infantile Gaucher's disease. Arch Pathol.\u20081967;83(6):513\u2013526"},{"key":"2021120902352169600_R74","doi-asserted-by":"crossref","unstructured":"Sidransky E, Tayebi N, Stubblefield BK, et al. The clinical, molecular, and pathological characterisation of a family with two cases of lethal perinatal type 2 Gaucher disease. J Med Genet.\u20081996;33(2):132\u2013136","DOI":"10.1136\/jmg.33.2.132"},{"key":"2021120902352169600_R75","doi-asserted-by":"crossref","unstructured":"Tasso MJ, Martinez-Gutierrez A, Carrascosa C, Vazquez S, Tebar R. GM1-gangliosidosis presenting as nonimmune hydrops fetalis: a case report. J Perinat Med.\u20081996;24(5):445\u2013449","DOI":"10.1515\/jpme.1996.24.5.445"},{"key":"2021120902352169600_R76","doi-asserted-by":"crossref","unstructured":"Yuksel A, Kayserili H, Gungor F. Short femurs detected at 25 and 31 weeks of gestation diagnosed as Leroy I-cell disease in the postnatal period: a report of two cases. Fetal Diagn Ther.\u20082007;22(3):198\u2013202","DOI":"10.1159\/000098717"},{"key":"2021120902352169600_R77","doi-asserted-by":"crossref","unstructured":"Aynaci FM, Cakir E, Aynaci O. A case of I-cell disease (mucolipidosis II) presenting with craniosynostosis. Childs Nerv Syst.\u20082002;18(12):707\u2013711","DOI":"10.1007\/s00381-002-0627-7"},{"key":"2021120902352169600_R78","doi-asserted-by":"crossref","unstructured":"Sidransky E, Fartasch M, Lee RE, et al. Epidermal abnormalities may distinguish type 2 from type 1 and type 3 of Gaucher disease. Pediatr Res.\u20081996;39(1):134\u2013141","DOI":"10.1203\/00006450-199601000-00020"},{"key":"2021120902352169600_R79","doi-asserted-by":"crossref","unstructured":"Lui K, Commens C, Choong R, Jaworski R. Collodion babies with Gaucher's disease. Arch Dis Child.\u20081988;63(7):854\u2013856","DOI":"10.1136\/adc.63.7.854"},{"key":"2021120902352169600_R80","doi-asserted-by":"crossref","unstructured":"Fujimoto A, Tayebi N, Sidransky E. Congenital ichthyosis preceding neurologic symptoms in two sibs with type 2 Gaucher disease. Am J Med Genet.\u20081995;59(3):356\u2013358","DOI":"10.1002\/ajmg.1320590315"},{"key":"2021120902352169600_R81","doi-asserted-by":"crossref","unstructured":"Mau U, Kendziorra H, Kaiser P, Enders H. Restrictive dermopathy: report and review. Am J Med Genet.\u20081997;71(2):179\u2013185","DOI":"10.1002\/(SICI)1096-8628(19970808)71:2<179::AID-AJMG11>3.0.CO;2-B"},{"key":"2021120902352169600_R82","doi-asserted-by":"crossref","unstructured":"Holleran WM, Ziegler SG, Goker-Alpan O, et al. Skin abnormalities as an early predictor of neurologic outcome in Gaucher disease. Clin Genet.\u20082006;69(4):355\u2013357","DOI":"10.1111\/j.1399-0004.2006.00589.x"},{"key":"2021120902352169600_R83","unstructured":"Rybojad M, Moraillon I, Ogier de Baulny H, Prigent F, Morel P. Extensive Mongolian spot related to Hurler disease [in French]. Ann Dermatol Venereol.\u20081999;126(1):35\u201337"},{"key":"2021120902352169600_R84","doi-asserted-by":"crossref","unstructured":"Sergi C, Beedgen B, Kopitz J, et al. Refractory congenital ascites as a manifestation of neonatal sialidosis: clinical, biochemical and morphological studies in a newborn Syrian male infant. Am J Perinatol.\u20081999;16(3):133\u2013141","DOI":"10.1055\/s-2007-993847"},{"key":"2021120902352169600_R85","doi-asserted-by":"crossref","unstructured":"Libert J, Van Hoof F, Farriaux JP, Toussaint D. Ocular findings in I-cell disease (mucolipidosis type II). Am J Ophthalmol.\u20081977;83(5):617\u2013628","DOI":"10.1016\/0002-9394(77)90126-X"},{"key":"2021120902352169600_R86","doi-asserted-by":"crossref","unstructured":"Tekinalp G, Aliefendiog\u0306lu D, Yu\u0308ce A, Cag\u0306lar M, Beck M. A case with early infantile form of galactosialidosis with unusual haematological findings. J Inherit Metab Dis.\u20081999;22(5):668\u2013669","DOI":"10.1023\/A:1005598517882"},{"key":"2021120902352169600_R87","unstructured":"Hutchison AA, Drew JH, Yu VY, Williams ML, Fortune DW, Beischer NA. Nonimmunologic hydrops fetalis: a review of 61 cases. Obstet Gynecol.\u20081982;59(3):347\u2013352"},{"key":"2021120902352169600_R88","doi-asserted-by":"crossref","unstructured":"Girgensohn H, Kellner H, Sudhof H. Congenital Gaucher's disease in erythroblastosis and vascular sclerosis [in German]. Klin Wochenschr.\u20081954;32(3\u20134):57\u201364","DOI":"10.1007\/BF01493524"},{"key":"2021120902352169600_R89","doi-asserted-by":"crossref","unstructured":"Nicolaides KH, Warenski JC, Rodeck CH. The relationship of fetal plasma protein concentration and hemoglobin level to the development of hydrops in rhesus isoimmunization. Am J Obstet Gynecol.\u20081985;152(3):341\u2013344","DOI":"10.1016\/S0002-9378(85)80224-6"},{"key":"2021120902352169600_R90","doi-asserted-by":"crossref","unstructured":"Piraud M, Froissart R, Mandon G, Bernard A, Maire I. Amniotic fluid for screening of lysosomal storage diseases presenting in utero (mainly as non-immune hydrops fetalis). Clin Chim Acta.\u20081996;248(2):143\u2013155","DOI":"10.1016\/0009-8981(95)06250-5"},{"key":"2021120902352169600_R91","doi-asserted-by":"crossref","unstructured":"Burin MG, Scholz AP, Gus R, et al. Investigation of lysosomal storage diseases in nonimmune hydrops fetalis. Prenat Diagn.\u20082004;24(8):653\u2013657","DOI":"10.1002\/pd.967"},{"key":"2021120902352169600_R92","doi-asserted-by":"crossref","unstructured":"Kooper AJ, Janssens PM, de Groot AN, et al. Lysosomal storage diseases in non-immune hydrops fetalis pregnancies. Clin Chim Acta.\u20082006;371(1\u20132):176\u2013182","DOI":"10.1016\/j.cca.2006.03.007"},{"key":"2021120902352169600_R93","unstructured":"Bouvier R, Maire I. Diagnosis of lysosomal storage diseases with fetal presentation [in French]. Ann Pathol.\u20081997;17(4):277\u2013280"},{"key":"2021120902352169600_R94","doi-asserted-by":"crossref","unstructured":"Ginsburg SJ, Groll M. Hydrops fetalis due to infantile Gaucher's disease. J Pediatr.\u20081973;82(6):1046\u20131048","DOI":"10.1016\/S0022-3476(73)80441-X"},{"key":"2021120902352169600_R95","doi-asserted-by":"crossref","unstructured":"Sun CC, Panny S, Combs J, Gutberlett R. Hydrops fetalis associated with Gaucher disease. Pathol Res Pract.\u20081984;179(1):101\u2013104","DOI":"10.1016\/S0344-0338(84)80069-2"},{"key":"2021120902352169600_R96","doi-asserted-by":"crossref","unstructured":"Sidransky E, Sherer DM, Ginns EI. Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene. Pediatr Res.\u20081992;32(4):494\u2013498","DOI":"10.1203\/00006450-199210000-00023"},{"key":"2021120902352169600_R97","unstructured":"Sherer DM, Metlay LA, Sinkin RA, Mongeon C, Lee RE, Woods JR Jr. Congenital ichthyosis with restrictive dermopathy and Gaucher disease: a new syndrome with associated prenatal diagnostic and pathology findings. Obstet Gynecol.\u20081993;81(5 pt 2):842\u2013844"},{"key":"2021120902352169600_R98","doi-asserted-by":"crossref","unstructured":"Strasberg PM, Skomorowski MA, Warren IB, Hilson WL, Callahan JW, Clarke JT. Homozygous presence of the crossover (fusion gene) mutation identified in a type II Gaucher disease fetus: is this analogous to the Gaucher knock-out mouse model?Biochem Med Metab Biol.\u20081994;53(1):16\u201321","DOI":"10.1006\/bmmb.1994.1052"},{"key":"2021120902352169600_R99","doi-asserted-by":"crossref","unstructured":"Tayebi N, Cushner SR, Kleijer W, et al. Prenatal lethality of a homozygous null mutation in the human glucocerebrosidase gene. Am J Med Genet.\u20081997;73(1):41\u201347","DOI":"10.1002\/(SICI)1096-8628(19971128)73:1<41::AID-AJMG9>3.0.CO;2-S"},{"key":"2021120902352169600_R100","doi-asserted-by":"crossref","unstructured":"Beck M, Bender SW, Reiter HL, et al. Neuraminidase deficiency presenting as non-immune hydrops fetalis. Eur J Pediatr.\u20081984;143(2):135\u2013139","DOI":"10.1007\/BF00445802"},{"key":"2021120902352169600_R101","doi-asserted-by":"crossref","unstructured":"Gillan JE, Lowden JA, Gaskin K, Cutz E. Congenital ascites as a presenting sign of lysosomal storage disease. J Pediatr.\u20081984;104(2):225\u2013231","DOI":"10.1016\/S0022-3476(84)80997-X"},{"key":"2021120902352169600_R102","unstructured":"Guibaud P, Cottin X, Maire I, et al. Fetal ascites as a manifestation of infantile sialidosis. Significance of a study of oligosaccharides in amniotic fluid [in French]. J Genet Hum.\u20081985;33(3\u20134):317\u2013324"},{"key":"2021120902352169600_R103","unstructured":"Schmidt M, Fahnenstich H, Haverkamp F, Platz H, Hansmann M, Bartmann P. Sialidosis and galactosialidosis as the cause of non-immunologic hydrops fetalis [in German]. Z Geburtshilfe Neonatol.\u20081997;201(5):177\u2013180"},{"key":"2021120902352169600_R104","unstructured":"Ovali F, Samanci N, Guray A, et al. Congenital sialidosis. Turk J Pediatr.\u20081998;40(3):447\u2013451"},{"key":"2021120902352169600_R105","doi-asserted-by":"crossref","unstructured":"Buchholz T, Molitor G, Lukong KE, et al. Clinical presentation of congenital sialidosis in a patient with a neuraminidase gene frameshift mutation. Eur J Pediatr.\u20082001;160(1):26\u201330","DOI":"10.1007\/PL00008412"},{"key":"2021120902352169600_R106","doi-asserted-by":"crossref","unstructured":"Sergi C, Penzel R, Uhl J, et al. Prenatal diagnosis and fetal pathology in a Turkish family harboring a novel nonsense mutation in the lysosomal alpha-N-acetyl-neuraminidase (sialidase) gene. Hum Genet.\u20082001;109(4):421\u2013428","DOI":"10.1007\/s004390100592"},{"key":"2021120902352169600_R107","doi-asserted-by":"crossref","unstructured":"Pattison S, Pankarican M, Rupar CA, Graham FL, Igdoura SA. Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus-mediated expression. Hum Mutat.\u20082004;23(1):32\u201339","DOI":"10.1002\/humu.10278"},{"key":"2021120902352169600_R108","doi-asserted-by":"crossref","unstructured":"Loren DJ, Campos Y, d'Azzo A, et al. Sialidosis presenting as severe nonimmune fetal hydrops is associated with two novel mutations in lysosomal alpha-neuraminidase. J Perinatol.\u20082005;25(7):491\u2013494","DOI":"10.1038\/sj.jp.7211335"},{"key":"2021120902352169600_R109","unstructured":"Landau D, Meisner I, Zeigler M, Bargal R, Shinwell ES. Hydrops fetalis in four siblings caused by galactosialidosis. Isr J Med Sci.\u20081995;31(5):321\u2013322"},{"key":"2021120902352169600_R110","doi-asserted-by":"crossref","unstructured":"Haverkamp F, Jacobs D, Cantz M, Hansmann M, Fahnenstich H, Zerres K. Nonimmune hydrops fetalis with galactosialidosis: consequences for family planning. Fetal Diagn Ther.\u20081996;11(2):114\u2013119","DOI":"10.1159\/000264289"},{"key":"2021120902352169600_R111","doi-asserted-by":"crossref","unstructured":"Claeys M, Van der Hoeven M, de Die-Smulders C, et al. Early-infantile type of galactosialidosis as a cause of heart failure and neonatal ascites. J Inherit Metab Dis.\u20081999;22(5):666\u2013667","DOI":"10.1023\/A:1005546501043"},{"key":"2021120902352169600_R112","unstructured":"Lefebvre G, Wehbe G, Heron D, Vautjoer Brouzes D, Choukroun JB, Darbois Y. Recurrent nonimmune hydrops fetalis: a rare presentation of sialic acid storage disease. Genet Couns.\u20081999;10(3):277\u2013284"},{"key":"2021120902352169600_R113","doi-asserted-by":"crossref","unstructured":"Lemyre E, Russo P, Melancon SB, Gagne R, Potier M, Lambert M. Clinical spectrum of infantile free sialic acid storage disease. Am J Med Genet.\u20081999;82(5):385\u2013391","DOI":"10.1002\/(SICI)1096-8628(19990219)82:5<385::AID-AJMG6>3.0.CO;2-3"},{"key":"2021120902352169600_R114","doi-asserted-by":"crossref","unstructured":"Landau D, Cohen D, Shalev H, et al. A novel mutation in the SLC17A5 gene causing both severe and mild phenotypes of free sialic acid storage disease in one inbred Bedouin kindred. Mol Genet Metab.\u20082004;82(2):167\u2013172","DOI":"10.1016\/j.ymgme.2004.03.005"},{"key":"2021120902352169600_R115","doi-asserted-by":"crossref","unstructured":"Applegarth DA, Toone JR, Wilson RD, Yong SL, Baldwin VJ. Morquio disease presenting as hydrops fetalis and enzyme analysis of chorionic villus tissue in a subsequent pregnancy. Pediatr Pathol.\u20081987;7(5\u20136):593\u2013599","DOI":"10.3109\/15513818709161423"},{"key":"2021120902352169600_R116","doi-asserted-by":"crossref","unstructured":"Beck M, Braun S, Coerdt W, Merz E, Young E, Sewell AC. Fetal presentation of Morquio disease type A. Prenat Diagn. 1992;12(12):1019\u20131029","DOI":"10.1002\/pd.1970121207"},{"key":"2021120902352169600_R117","doi-asserted-by":"crossref","unstructured":"Colmant C, Picone O, Froissart R, Labrune P, Senat MV. Second-trimester diagnosis of mucopolysaccharidosis type IV a presenting as hydrops fetalis. Prenat Diagn.\u20082006;26(8):750\u2013752","DOI":"10.1002\/pd.1467"},{"key":"2021120902352169600_R118","doi-asserted-by":"crossref","unstructured":"Nelson A, Peterson L, Frampton B, Sly WS. Mucopolysaccharidosis VII (beta-glucuronidase deficiency) presenting as nonimmune hydrops fetalis. J Pediatr.\u20081982;101(4):574\u2013576","DOI":"10.1016\/S0022-3476(82)80707-5"},{"key":"2021120902352169600_R119","doi-asserted-by":"crossref","unstructured":"Islam MR, Shah GN, Sly WS. PCR-based restriction fragment length polymorphism and haplotype of the most common mutation L176F in the beta-glucuronidase gene. Genet Test.\u20082007;11(1):72\u201374","DOI":"10.1089\/gte.2006.0505"},{"key":"2021120902352169600_R120","unstructured":"Vervoort R, Islam MR, Sly WS, et al. Molecular analysis of patients with beta-glucuronidase deficiency presenting as hydrops fetalis or as early mucopolysaccharidosis VII. Am J Hum Genet.\u20081996;58(3):457\u2013471"},{"key":"2021120902352169600_R121","doi-asserted-by":"crossref","unstructured":"Abu-Dalu KI, Tamary H, Livni N, Rivkind AI, Yatziv S. GM1 gangliosidosis presenting as neonatal ascites. J Pediatr.\u20081982;100(6):940\u2013943","DOI":"10.1016\/S0022-3476(82)80523-4"},{"key":"2021120902352169600_R122","unstructured":"Vajro P, Strisciuglio P, Fontanella A, De Vincenzo A. Neonatal ascites disclosing GM1 gangliosidosis [in French]. Arch Fr Pediatr.\u20081990;47(7):544"},{"key":"2021120902352169600_R123","doi-asserted-by":"crossref","unstructured":"Sinelli MT, Motta M, Cattarelli D, Cardone ML, Chirico G. Fetal hydrops in GM(1) gangliosidosis: a case report. Acta Paediatr.\u20082005;94(12):1847\u20131849","DOI":"10.1111\/j.1651-2227.2005.tb01867.x"},{"key":"2021120902352169600_R124","doi-asserted-by":"crossref","unstructured":"Meizner I, Levy A, Carmi R, Robinsin C. Niemann-Pick disease associated with nonimmune hydrops fetalis. Am J Obstet Gynecol.\u20081990;163(1 pt 1):128\u2013129","DOI":"10.1016\/S0002-9378(11)90685-1"},{"key":"2021120902352169600_R125","doi-asserted-by":"crossref","unstructured":"Ben-Haroush A, Yogev Y, Levit O, Hod M, Kaplan B. Isolated fetal ascites caused by Wolman disease. Ultrasound Obstet Gynecol.\u20082003;21(3):297\u2013298","DOI":"10.1002\/uog.73"},{"key":"2021120902352169600_R126","doi-asserted-by":"crossref","unstructured":"Kattner E, Schafer A, Harzer K. Hydrops fetalis: manifestation in lysosomal storage diseases including Farber disease. Eur J Pediatr.\u20081997;156(4):292\u2013295","DOI":"10.1007\/s004310050603"},{"key":"2021120902352169600_R127","doi-asserted-by":"crossref","unstructured":"Roberts DJ, Ampola MG, Lage JM. Diagnosis of unsuspected fetal metabolic storage disease by routine placental examination. Pediatr Pathol.\u20081991;11(4):647\u2013656","DOI":"10.3109\/15513819109064796"},{"key":"2021120902352169600_R128","doi-asserted-by":"crossref","unstructured":"Nelson J, Kenny B, O'Hara D, Harper A, Broadhead D. Foamy changes of placental cells in probable beta glucuronidase deficiency associated with hydrops fetalis. J Clin Pathol.\u20081993;46(4):370\u2013371","DOI":"10.1136\/jcp.46.4.370"},{"key":"2021120902352169600_R129","doi-asserted-by":"crossref","unstructured":"Molyneux AJ, Blair E, Coleman N, Daish P. Mucopolysaccharidosis type VII associated with hydrops fetalis: histopathological and ultrastructural features with genetic implications. J Clin Pathol.\u20081997;50(3):252\u2013254","DOI":"10.1136\/jcp.50.3.252"},{"key":"2021120902352169600_R130","doi-asserted-by":"crossref","unstructured":"Hale LP, van de Ven CJ, Wenger DA, Bradford WD, Kahler SG. Infantile sialic acid storage disease: a rare cause of cytoplasmic vacuolation in pediatric patients. Pediatr Pathol Lab Med.\u20081995;15(3):443\u2013453","DOI":"10.3109\/15513819509026980"},{"key":"2021120902352169600_R131","doi-asserted-by":"crossref","unstructured":"Froissart R, Cheillan D, Bouvier R, et al. Clinical, morphological, and molecular aspects of sialic acid storage disease manifesting in utero. J Med Genet.\u20082005;42(11):829\u2013836","DOI":"10.1136\/jmg.2004.029744"},{"key":"2021120902352169600_R132","doi-asserted-by":"crossref","unstructured":"Soma H, Yamada K, Osawa H, Hata T, Oguro T, Kudo M. Identification of Gaucher cells in the chorionic villi associated with recurrent hydrops fetalis. Placenta.\u20082000;21(4):412\u2013416","DOI":"10.1053\/plac.1999.0483"},{"key":"2021120902352169600_R133","doi-asserted-by":"crossref","unstructured":"Groener J, Maaswinkel-Mooy P, Smit V, et al. New mutations in two Dutch patients with early infantile galactosialidosis. Mol Genet Metab.\u20082003;78(3):222\u2013228","DOI":"10.1016\/S1096-7192(03)00005-2"},{"key":"2021120902352169600_R134","doi-asserted-by":"crossref","unstructured":"Vedder AC, Strijland A, vd Bergh Weerman MA, Florquin S, Aerts JM, Hollak CE. Manifestations of Fabry disease in placental tissue. J Inherit Metab Dis.\u20082006;29(1):106\u2013111","DOI":"10.1007\/s10545-006-0196-0"},{"key":"2021120902352169600_R135","doi-asserted-by":"crossref","unstructured":"Venkat-Raman N, Sebire NJ, Murphy KW. Recurrent fetal hydrops due to mucopolysaccharidoses type VII. Fetal Diagn Ther.\u20082006;21(3):250\u2013254","DOI":"10.1159\/000091350"},{"key":"2021120902352169600_R136","doi-asserted-by":"crossref","unstructured":"Manning DJ, Price WI, Pearse RG. Fetal ascites: an unusual presentation of Niemann-Pick disease type C. Arch Dis Child. 1990;65(3):335\u2013336","DOI":"10.1136\/adc.65.3.335-e"},{"key":"2021120902352169600_R137","doi-asserted-by":"crossref","unstructured":"Meikle PJ, Hopwood JJ. Lysosomal storage disorders: emerging therapeutic options require early diagnosis. Eur J Pediatr.\u20082003;162(suppl 1):S34\u2013S37","DOI":"10.1007\/s00431-003-1348-y"},{"key":"2021120902352169600_R138","doi-asserted-by":"crossref","unstructured":"Meikle PJ, Fietz MJ, Hopwood JJ. Diagnosis of lysosomal storage disorders: current techniques and future directions. Expert Rev Mol Diagn.\u20082004;4(5):677\u2013691","DOI":"10.1586\/14737159.4.5.677"},{"key":"2021120902352169600_R139","doi-asserted-by":"crossref","unstructured":"Harzer K, Cantz M, Sewell AC, et al. Normomorphic sialidosis in two female adults with severe neurologic disease and without sialyl oligosacchariduria. Hum Genet.\u20081986;74(3):209\u2013214","DOI":"10.1007\/BF00282535"},{"key":"2021120902352169600_R140","doi-asserted-by":"crossref","unstructured":"Peelen GO, de Jong JG, Wevers RA. HPLC analysis of oligosaccharides in urine from oligosaccharidosis patients. Clin Chem.\u20081994;40(6):914\u2013921","DOI":"10.1093\/clinchem\/40.6.914"},{"key":"2021120902352169600_R141","doi-asserted-by":"crossref","unstructured":"Harzer K, Rolfs A, Bauer P, et al. Niemann-Pick disease type A and B are clinically but also enzymatically heterogeneous: pitfall in the laboratory diagnosis of sphingomyelinase deficiency associated with the mutation Q292 K. Neuropediatrics. 2003;34(6):301\u2013306","DOI":"10.1055\/s-2003-44668"},{"key":"2021120902352169600_R142","unstructured":"Brooks DA, McCourt PA, Gibson GJ, Ashton LJ, Shutter M, Hopwood JJ. Analysis of N-acetylgalactosamine-4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patients. Am J Hum Genet.\u20081991;48(4):710\u2013719"},{"key":"2021120902352169600_R143","doi-asserted-by":"crossref","unstructured":"Umapathysivam K, Hopwood JJ, Meikle PJ. Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease. Clin Chem.\u20082001;47(8):1378\u20131383","DOI":"10.1093\/clinchem\/47.8.1378"},{"key":"2021120902352169600_R144","doi-asserted-by":"crossref","unstructured":"Carpenter KH, Wiley V. Application of tandem mass spectrometry to biochemical genetics and newborn screening. Clin Chim Acta.\u20082002;322(1\u20132):1\u201310","DOI":"10.1016\/S0009-8981(02)00135-3"},{"key":"2021120902352169600_R145","doi-asserted-by":"crossref","unstructured":"Chace DH, Kalas TA, Naylor EW. The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism. Annu Rev Genomics Hum Genet.\u20082002;3:17\u201345","DOI":"10.1146\/annurev.genom.3.022502.103213"},{"key":"2021120902352169600_R146","doi-asserted-by":"crossref","unstructured":"Beck M. New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy. Hum Genet.\u20082007;121(1):1\u201322","DOI":"10.1007\/s00439-006-0280-4"},{"key":"2021120902352169600_R147","doi-asserted-by":"crossref","unstructured":"Malatack JJ, Consolini DM, Bayever E. The status of hematopoietic stem cell transplantation in lysosomal storage disease. Pediatr Neurol.\u20082003;29(5):391\u2013403","DOI":"10.1016\/j.pediatrneurol.2003.09.003"},{"key":"2021120902352169600_R148","doi-asserted-by":"crossref","unstructured":"Krivit W. Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases. Springer Semin Immunopathol.\u20082004;26(1\u20132):119\u2013132","DOI":"10.1007\/s00281-004-0166-2"},{"key":"2021120902352169600_R149","doi-asserted-by":"crossref","unstructured":"Boelens JJ. Trends in haematopoietic cell transplantation for inborn errors of metabolism. J Inherit Metab Dis.\u20082006;29(2\u20133):413\u2013420","DOI":"10.1007\/s10545-005-0258-8"},{"key":"2021120902352169600_R150","doi-asserted-by":"crossref","unstructured":"Orchard PJ, Blazar BR, Wagner J, Charnas L, Krivit W, Tolar J. Hematopoietic cell therapy for metabolic disease. J Pediatr.\u20082007;151(4):340\u2013346","DOI":"10.1016\/j.jpeds.2007.04.054"},{"key":"2021120902352169600_R151","doi-asserted-by":"crossref","unstructured":"Peters C, Steward CG. Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines. Bone Marrow Transplant.\u20082003;31(4):229\u2013239","DOI":"10.1038\/sj.bmt.1703839"},{"key":"2021120902352169600_R152","doi-asserted-by":"crossref","unstructured":"Staba SL, Escolar ML, Poe M, et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med.\u20082004;350(19):1960\u20131969","DOI":"10.1056\/NEJMoa032613"},{"key":"2021120902352169600_R153","doi-asserted-by":"crossref","unstructured":"Escolar ML, Poe MD, Provenzale JM, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med.\u20082005;352(20):2069\u20132081","DOI":"10.1056\/NEJMoa042604"},{"key":"2021120902352169600_R154","doi-asserted-by":"crossref","unstructured":"Koc\u0327 ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant.\u20082002;30(4):215\u2013222","DOI":"10.1038\/sj.bmt.1703650"},{"key":"2021120902352169600_R155","doi-asserted-by":"crossref","unstructured":"Mu\u0308ller I, Kustermann-Kuhn B, Holzwarth C, et al. In vitro analysis of multipotent mesenchymal stromal cells as potential cellular therapeutics in neurometabolic diseases in pediatric patients. Exp Hematol.\u20082006;34(10):1413\u20131419","DOI":"10.1016\/j.exphem.2006.06.007"},{"key":"2021120902352169600_R156","doi-asserted-by":"crossref","unstructured":"Butters TD. Pharmacotherapeutic strategies using small molecules for the treatment of glycolipid lysosomal storage disorders. Expert Opin Pharmacother.\u20082007;8(4):427\u2013435","DOI":"10.1517\/14656566.8.4.427"},{"key":"2021120902352169600_R157","doi-asserted-by":"crossref","unstructured":"Yam GH, Bosshard N, Zuber C, Steinmann B, Roth J. Pharmacological chaperone corrects lysosomal storage in Fabry disease caused by trafficking-incompetent variants. Am J Physiol Cell Physiol.\u20082006;290(4):C1076\u2013C1082","DOI":"10.1152\/ajpcell.00426.2005"},{"key":"2021120902352169600_R158","doi-asserted-by":"crossref","unstructured":"Fan JQ, Ishii S. Active-site-specific chaperone therapy for Fabry disease: yin and yang of enzyme inhibitors. FEBS J.\u20082007;274(19):4962\u20134971","DOI":"10.1111\/j.1742-4658.2007.06041.x"},{"key":"2021120902352169600_R159","doi-asserted-by":"crossref","unstructured":"Hollak CE, Vedder AC, Linthorst GE, Aerts JM. Novel therapeutic targets for the treatment of Fabry disease. Expert Opin Ther Targets.\u20082007;11(6):821\u2013833","DOI":"10.1517\/14728222.11.6.821"},{"key":"2021120902352169600_R160","doi-asserted-by":"crossref","unstructured":"Butters TD. Gaucher disease. Curr Opin Chem Biol.\u20082007;11(4):412\u2013418","DOI":"10.1016\/j.cbpa.2007.05.035"},{"key":"2021120902352169600_R161","doi-asserted-by":"crossref","unstructured":"Yu Z, Sawkar AR, Kelly JW. Pharmacologic chaperoning as a strategy to treat Gaucher disease. FEBS J.\u20082007;274(19):4944\u20134950","DOI":"10.1111\/j.1742-4658.2007.06042.x"},{"key":"2021120902352169600_R162","doi-asserted-by":"crossref","unstructured":"Okumiya T, Kroos MA, Vliet LV, Takeuchi H, Van der Ploeg AT, Reuser AJ. Chemical chaperones improve transport and enhance stability of mutant alpha-glucosidases in glycogen storage disease type II. Mol Genet Metab.\u20082007;90(1):49\u201357","DOI":"10.1016\/j.ymgme.2006.09.010"},{"key":"2021120902352169600_R163","doi-asserted-by":"crossref","unstructured":"Parenti G, Zuppaldi A, Gabriela Pittis M, et al. Pharmacological enhancement of mutated alpha-glucosidase activity in fibroblasts from patients with Pompe disease. Mol Ther.\u20082007;15(3):508\u2013514","DOI":"10.1038\/sj.mt.6300074"},{"key":"2021120902352169600_R164","doi-asserted-by":"crossref","unstructured":"Iwasaki H, Watanabe H, Iida M, et al. Fibroblast screening for chaperone therapy in beta-galactosidosis. Brain Dev.\u20082006;28(8):482\u2013486","DOI":"10.1016\/j.braindev.2006.02.002"},{"key":"2021120902352169600_R165","doi-asserted-by":"crossref","unstructured":"Tropak MB, Reid SP, Guiral M, Withers SG, Mahuran D. Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff patients. J Biol Chem.\u20082004;279(14):13478\u201313487","DOI":"10.1074\/jbc.M308523200"},{"key":"2021120902352169600_R166","doi-asserted-by":"crossref","unstructured":"Zheng W, Padia J, Urban DJ, et al. Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease. Proc Natl Acad Sci USA. 2007;104(32):13192\u201313197","DOI":"10.1073\/pnas.0705637104"},{"key":"2021120902352169600_R167","doi-asserted-by":"crossref","unstructured":"Tropak MB, Blanchard JE, Withers SG, Brown ED, Mahuran D. High-throughput screening for human lysosomal beta-N-acetyl hexosaminidase inhibitors acting as pharmacological chaperones. Chem Biol.\u20082007;14(2):153\u2013164","DOI":"10.1016\/j.chembiol.2006.12.006"},{"key":"2021120902352169600_R168","doi-asserted-by":"crossref","unstructured":"Hodges BL, Cheng SH. Cell and gene-based therapies for the lysosomal storage diseases. Curr Gene Ther.\u20082006;6(2):227\u2013241","DOI":"10.2174\/156652306776359522"},{"key":"2021120902352169600_R169","doi-asserted-by":"crossref","unstructured":"Sands MS, Davidson BL. Gene therapy for lysosomal storage diseases. Mol Ther.\u20082006;13(5):839\u2013849","DOI":"10.1016\/j.ymthe.2006.01.006"},{"key":"2021120902352169600_R170","doi-asserted-by":"crossref","unstructured":"Dunbar CE, Kohn DB, Schiffmann R, et al. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation. Hum Gene Ther.\u20081998;9(17):2629\u20132640","DOI":"10.1089\/10430349850019463"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/123\/4\/1191\/1022664\/zpe00409001191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/123\/4\/1191\/1022664\/zpe00409001191.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T06:15:45Z","timestamp":1710224145000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/123\/4\/1191\/71385\/Lysosomal-Storage-Disorders-in-the-Newborn"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,1]]},"references-count":170,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,4,1]]},"published-print":{"date-parts":[[2009,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2008-0635","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,1]]}}}